Faeth Therapeutics (FTH) Short Interest
Nasdaq • FTH • US81728A2078
As of Oct 26, 2026, ORTEX estimated 10% of free float sold short, 5.3 days to cover, cost to borrow 4.52%. Sign up for live short interest data.
Nasdaq • FTH • US81728A2078
As of Oct 26, 2026, ORTEX estimated 10% of free float sold short, 5.3 days to cover, cost to borrow 4.52%. Sign up for live short interest data.
This page tracks how heavily Faeth Therapeutics (Nasdaq:FTH) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Faeth Therapeutics (Nasdaq: FTH) has a market capitalization of $327.66M. Last close $12.68 (as of 2026-11-10); 52-week range $7.45 to $42.14. ORTEX data as of 2026-10-26: short interest was 10.03% of free float, 5.3 days to cover and the average cost to borrow was 4.52%. Sign up for live short interest data.